Detalhe da pesquisa
1.
Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.
AIDS Behav
; 28(3): 936-950, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971614
2.
Extended post-exposure protection against vaginal SHIV infection with tenofovir alafenamide fumarate/elvitegravir inserts in macaques.
J Infect Dis
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134382
3.
HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa.
AIDS Behav
; 26(9): 3099-3109, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35360893
4.
End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa.
BMC Infect Dis
; 22(1): 919, 2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482336
5.
Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings.
AIDS Behav
; 25(1): 124-138, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588257
6.
Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment.
AIDS Behav
; 24(5): 1443-1451, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696371
7.
Re-assessing the Validity of the Opioid Risk Tool in a Tertiary Academic Pain Management Center Population.
Pain Med
; 19(7): 1382-1395, 2018 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29408996
8.
Multipurpose Prevention Approaches with Antiretroviral-Based Formulations.
Antimicrob Agents Chemother
; 60(2): 1141-4, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26596943
9.
Pharmacokinetic and safety analyses of tenofovir and tenofovir-emtricitabine vaginal tablets in pigtailed macaques.
Antimicrob Agents Chemother
; 58(5): 2665-74, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24566178
10.
Preclinical and Early Clinical Development of Tenofovir Alafenamide/Elvitegravir Topical Inserts for Effective On-Demand Vaginal and Rectal HIV Prevention.
Pharmaceutics
; 16(3)2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543242
11.
Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model.
Antimicrob Agents Chemother
; 56(6): 3058-66, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22430977
12.
Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.
Antimicrob Agents Chemother
; 56(2): 875-82, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22123689
13.
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.
Antimicrob Agents Chemother
; 56(12): 6272-83, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23006751
14.
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges.
Expert Opin Drug Deliv
; 19(10): 1365-1380, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36252277
15.
Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: a review of recent advances and clinical applications.
Expert Opin Drug Deliv
; 19(1): 47-58, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34958283
16.
Development and Preclinical Investigation of Physically Cross-Linked and pH-Sensitive Polymeric Gels as Potential Vaginal Contraceptives.
Polymers (Basel)
; 14(9)2022 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35566897
17.
Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaques.
EBioMedicine
; 86: 104338, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36343572
18.
Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring.
Front Cell Infect Microbiol
; 12: 799501, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35350436
19.
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
PLoS One
; 17(10): e0275794, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36215267
20.
Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaques.
EBioMedicine
; 86: 104361, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423375